Skip to main content

STOK- Stoke Therapeutics, Inc.

Insider activity in STOK over the last quarter tilts toward selling: insiders offloaded a net 7,176 shares worth roughly $208K. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.

Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), STOK's insider flows are most useful compared with peers in the same group.

Compare Health Care sector insider flows →

Insider Ownership

RoleInsiderSharesValue30d
CEO380.0K$12.43M-
Dir283.3K$9.27M-
Other118.7K$3.88M-
Dir35.5K$1.16M-
Dir30.8K$1.01M-

Activity

Buys and sells only

Transactions

10 filings
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Aug 3, 2026Ticho Barry50Chief Medical OfficerSell7,176$29.04$208,385.24-14.6%--
Mar 10, 2026Krainer Adrian R.DirectorSell33,243$39.74$1,320,963.79-10.5%-21.8%-
Mar 10, 2026Tzianabos Arthur77Interim Executive ChairSale+OE4,355$40.00$174,214.37-12.2%-21.8%-
Dec 8, 2025Kaye Edward M. Md46DirectorSell13,430$32.27$433,385.06-7.8%+16.0%-
Dec 8, 2025Allan Jonathan46General Counsel &Corp SecSell3,978$32.28$128,411.36-13.1%+16.0%-
Dec 5, 2025Allan Jonathan46General Counsel &Corp SecSale+OE9,803$31.25$306,322.15-8.4%+12.2%-
Dec 5, 2025Kaye Edward M. Md46DirectorSale+OE15,001$31.13$466,958.91-4.3%+12.2%-
Dec 5, 2025Ticho Barry50Chief Medical OfficerSale+OE5,358$31.19$167,115.04-5.7%+12.2%-
Dec 3, 2025Ticho Barry50Chief Medical OfficerSale+OE4,020$30.22$121,468.37-5.7%+9.1%-
Dec 3, 2025Kaye Edward M. Md46DirectorSale+OE1,070$30.65$32,793.47-1.0%+9.1%-
Page 1Next →

Understand these filings